序号 |
标题 |
次数 |
作者 |
发布时间 |
85681 |
DOTA-SiMPs ,介孔硅纳米结构(SiMPs)共轭四氮杂环十二烷四乙酸(DOTA) |
176 |
kx |
2024-11-29 |
85682 |
FITC标记TAT穿膜肽 ;Gd-DTPA-ACPP |
136 |
wyh |
2024-11-29 |
85683 |
DOTA-Octreotide ,DOTA-奥曲肽 |
116 |
wyh |
2024-11-29 |
85684 |
单克隆抗体B72.3偶联DOTA ,DOTA-B72.3 |
165 |
kx |
2024-11-29 |
85685 |
螯合剂多肽cyclo(RGDFK(DOTA)) ,DOTA-c(RGDfK) |
137 |
wyh |
2024-11-29 |
85686 |
NOTA-(COOt-Bu)2 cas:1161415-28-6 |
134 |
zyl |
2024-11-29 |
85687 |
DOTA-JR10多肽的功能特点 |
176 |
wyh |
2024-11-29 |
85688 |
Biotin-Gd-DOTA ;生物素修饰的钆 |
107 |
wyh |
2024-11-29 |
85689 |
DOTA-CC9 ,细胞膜的环肽CC9偶联DOTA |
227 |
kx |
2024-11-29 |
85690 |
1,4,7,10-四氮杂环十二烷-N.N ',N ",N " '-四乙酸(H4DOTA) |
330 |
kx |
2024-11-29 |
85691 |
NOTA-bis-COOH-Me-Tetrazine 大环配体NOTA-三羧酸-甲基四嗪 |
120 |
zyl |
2024-11-29 |
85692 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[(diphosphonomethyl)amino]-2-oxoethyl]- 定制 |
143 |
zcy |
2024-11-29 |
85693 |
DOTA-pNO2Phe-c[DCys-Tyr-DTrp-Lys-Thr-Cys]-DTyr-NH2 |
235 |
kx |
2024-11-29 |
85694 |
MeTz-PEG7-NOTA 甲基四嗪-聚乙二醇-大环化合物 Me-Tetrazine-PEG7-NOTA |
105 |
zyl |
2024-11-29 |
85695 |
DOTAGA-四叔丁酯,306776-79-4,DOTAGA-(COOt-Bu)4 |
200 |
zcy |
2024-11-29 |
85696 |
金刚烷改性氰酸酯树脂 AD-CE |
209 |
h |
2024-11-29 |
85697 |
DOTA-Tyr-Lys-DOTA ;DOTA-酪氨酸-赖氨酸-DOTA |
98 |
wyh |
2024-11-29 |
85698 |
HA-DOTA tate , DOTA-3-碘-Tyr 3-奥曲肽 , HA-DOTATATE |
131 |
kx |
2024-11-29 |
85699 |
NOTA-E(cRGDfK)2 , NOTA修饰多肽 |
130 |
wyh |
2024-11-29 |
85700 |
叠氮-NOTA cas:2125661-92-7 NOTA-Azide/N3 |
138 |
zyl |
2024-11-29 |
85701 |
金刚烷改性壳聚糖 AD-CS |
178 |
h |
2024-11-29 |
85702 |
DOTA-c(RGDfK) , 螯合物前体多肽 |
171 |
wyh |
2024-11-29 |
85703 |
DOTA-Lys-PEG(4)[D-Phe(6) |
121 |
kx |
2024-11-29 |
85704 |
葫芦[7]脲包裹盐酸金刚烷胺 CB[7]-AD |
165 |
h |
2024-11-29 |
85705 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, 2,2,2-trifluoroacetate (1:) 定制 |
116 |
zcy |
2024-11-29 |
85706 |
N-金刚烷基-N-芳杂基二酰肼类化合物 |
211 |
h |
2024-11-29 |
85707 |
DOTA-奥曲肽 ,DOTA-Octreotide |
143 |
wyh |
2024-11-29 |
85708 |
CAS:147597-66-8 p-SCN-Bn-NOTA |
114 |
zyl |
2024-11-29 |
85709 |
金刚烷衍生物 |
199 |
h |
2024-11-29 |
85710 |
NOTA-EXENDIN-4 |
112 |
zyl |
2024-11-29 |
85711 |
DOTA-PDAP-PNA-肽探针 |
117 |
kx |
2024-11-29 |
85712 |
β-环糊精磁性棕榈纤维生物炭 β-CD@PFMBC |
170 |
h |
2024-11-29 |
85713 |
DOTA-octreotide ,DOTA-奥曲肽 ,大环配体多肽 |
154 |
wyh |
2024-11-29 |
85714 |
β-环糊精包埋β-胡萝卜素 β-C-β-CD |
187 |
h |
2024-11-29 |
85715 |
DOTA-8-氨基辛酸 , DOTA-8-amino octanoic acid |
124 |
kx |
2024-11-29 |
85716 |
NOTA-Me-Tetrazine NOTA-甲基四嗪 |
119 |
zyl |
2024-11-29 |
85717 |
环糊精类手性离子液体(β-CD-IL) |
276 |
h |
2024-11-29 |
85718 |
DOTA-[D-Glu(1-6) , 谷氨酸残基的结构化接头DOTA |
160 |
kx |
2024-11-29 |
85719 |
DOTA-多肽分子探针 ,RGD多肽偶联的酞菁硅光敏剂 |
139 |
wyh |
2024-11-29 |
85720 |
金属离子配合物NO2A-Butyne,2089035-56-1 |
198 |
zyl |
2024-11-29 |
85721 |
DOTA-2P-[FAPI]2, FAP抑制剂(FAPI)二聚体 |
275 |
kx |
2024-11-29 |
85722 |
1293368-74-7;DOTA标记的多肽 |
142 |
wyh |
2024-11-29 |
85723 |
透明质酸-羟丙基-β-环糊精主动靶向接枝物(HA-CDs,分子量为7,63,102 kDa) |
215 |
h |
2024-11-29 |
85724 |
载脂蛋白E衍生肽-NOTA |
155 |
zyl |
2024-11-29 |
85725 |
DOTA-HYNIC-Lys(Nal)-Urea-Glu , DOTA HYNIC-Lys(Nal)-尿素-谷氨酸 |
123 |
kx |
2024-11-29 |